469 Therapy monitoring of Sorafenib effect on experimental prostate carcinomas using dynamic contrast-enhanced (DCE)-MRI with Gadobutrol and immunohistochemical analyses

C.C. Cyran, P.M. Paprottka, B. Schwarz, C.J. Bruns, O. Dietrich, R. Hinkel, J. Von Einem, M.F. Reiser, K. Nikolaou, B.J. Wintersperger
  • European Journal of Cancer Supplements, November 2010, Elsevier
  • DOI: 10.1016/s1359-6349(10)72176-5

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/s1359-6349(10)72176-5

The following have contributed to this page: Olaf Dietrich